
Lefteris Mylonakis retweeted
Program Available: 7th International Conference on #ModelHosts in #Crete #Greece from Oct. 12-17. Registration still open! aegeanconferences.org/src/Ap…
Lefteris Mylonakis retweeted
Had a great first visit (in this role) to @WeillCornell partners @MethodistHosp Enjoyed hearing about academic programs. Appreciate the
20 year relationship and Dean Gotto’s vision. Thanks to @WilliamZoghbi and Dr Mylonakis
Lefteris Mylonakis retweeted
🚨⏰🔔😳‼️😳🔔⏰🚨
How much ongoing regulatory training do academic professors need every year?
After completing many hours of CITI training for clinical research/hospital with 16 modules on different topics with a detailed module on different types of COI (including COI outside the conduct of clinical research),
now I need to complete overdue COI training for academic department/university. How much COI training is needed with ongoing disclosure requirements and oversight in place.
Our academicians especially physician-scientists need to be able to do their work and not be constantly asked to repeat training on a never ending list of topics.
Much time is already spent on grant writing in an often futile cycle due to low funding rates and limited resources. Grant reporting has also gotten more complex and time-consuming.
The system is in desperate need of reform.
@nasem @NIH @AmericanCancer @ASCO @AACR @theNCI @TheCancerLetter @ScienceMagazine @Nature
Lefteris Mylonakis retweeted
Is infectious disease consultation cost-effective for the management of Staphylococcus aureus bacteremia?
🆕⚡Economic evaluation using a decision-analytic model might provide an answer! #IDTwitter #MedEd #TwitteRx #MedTwitter
jamanetwork.com/journals/jam…
Lefteris Mylonakis retweeted
An analysis in OFID found significant variability in mortality and impact of COVID-19 between countries in the #EuropeanUnion, even if they shared the same regulatory framework.
📄: https://nitter.cf/t.co/gc1ZMPqrHy
#IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @ElMylonakis
Lefteris Mylonakis retweeted
What would have the biggest impact on increasing US vaccinations isn't incentives, lotteries, or conveniences. It is @US_FDA giving vaccines full licensure, setting up requirements by military, health systems, & employers. That may happen sooner than anticipated. Like next month
Lefteris Mylonakis retweeted
Two million-plus petitions were sent to the White House in hopes of convincing the Biden administration to support a proposal that would temporarily waive trade agreement provisions in a bid to widen access to Covid-19 vaccines in low-income countries. buff.ly/3euuAht
Lefteris Mylonakis retweeted
Lefteris Mylonakis retweeted
No data suggesting lower efficacy of AstraZeneca vaccine: German health ministry reut.rs/3a1TKSx
Lefteris Mylonakis retweeted
The Massachusetts Department of Public Health today announced that the first case of the COVID-19 variant B.1.1.7 has been detected in Massachusetts. This is the same variant initially discovered in the United Kingdom. mass.gov/news/department-of-…
Lefteris Mylonakis retweeted
Sinovac's CoronaVac vaccine has been bought by countries with promises of high efficacy
Brazil just burst that bubble
Brazilian researchers report the CoronaVac efficacy is 50.4%
This is why we need published phase 3 trials before celebrations
www1.folha.uol.com.br/equili…
Lefteris Mylonakis retweeted
We mapped how all mutations to #SARSCoV2 receptor-binding domain (RBD) affect recognition by convalescent polyclonal human sera (biorxiv.org/content/10.1101/…).
Among implications: E484K (South African lineage) worrying for immune escape; RBD mutations in UK lineage less so (1/n).
Lefteris Mylonakis retweeted
The world is “losing its ability” to use “critically important” antibiotics, says @DrTedros. And #COVID19 is making this worse.
But the number of countries tracking resistant infections has tripled in 2 years, reports @WHO. This data can #StopSuperbugs
who.int/news-room/detail/01-…
Lefteris Mylonakis retweeted
US Nat'l Academies zoom Tues-Fri on long-term impact of AMR. Tues - push and pull incentives (agenda below); Wed - diagnostics; Thurs - stewardship, including alternatives in agriculture; Friday - anthropology & global burden of AMR. Register (free) here: nationalacademies.org/event/…
Lefteris Mylonakis retweeted
Replying to @rafaaraos
Hola, here is your unroll: The following info is directly from who.int/csr/don/31-dec… & thehealthsite.com/news/who-r…… Commentary and info… threadreaderapp.com/thread/1… Have a good day. 🤖
Lefteris Mylonakis retweeted
Here's a chart of the percentage of distributed Covid-19 vaccine doses that have been administered (from latest CDC data yesterday — thanks @DataDrivenMD for the data help). In addition to Bureau of Prisons (a federal agency), SD, DC, CT, ND and ME are in the top 5.
Lefteris Mylonakis retweeted
Do you think SARS-CoV-2 Lineage B.1.1.7 is now in your state?
90%Yes
0%No
10%Will be within 2 weeks
0%Already found(CO, CA, FL)
10 votes • Final results Lefteris Mylonakis retweeted
BREAKING: from the Royal London Hospital, this email from management👇
“We are now in disaster medicine mode. We are no longer providing high standard critical care, because we cannot”
The content of this email is SHOCKING and I’m passing it to a trusted journalist right now🚨
Lefteris Mylonakis retweeted
Simply put, the whole world needs to have access to vaccination. We are all in the same leaky boat. It is both an injustice and a risk for us all if COVID persists anywhere.




























